Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 500mg, Clavulanic Acid (potassium) - 125mg	625mg	Tablet	639,958 L.L
N03AE01	RIVOTRIL	B	Clonazepam - 2mg	2mg	Tablet, scored	503,941 L.L
N05AX13	INVEGA	B	Paliperidone - 3mg	3mg	Tablet, prolonged release	5,386,121 L.L
S02CA02	VIOCORTENE	B	Clioquinol - 10mg/ml, Flumetasone pivalate - 0.2mg/ml		Drops	568,253 L.L
A07EA06	CORTIMENT MMX	B	Budesonide - 9mg	9mg	Tablet, prolonged release	8,996,996 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	13,394,024 L.L
G04BE03	VIAGRA	B	Sildenafil (citrate) - 100mg	100mg	Tablet, film coated	2,089,675 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	46,628,557 L.L
N05AX13	INVEGA	B	Paliperidone - 6mg	6mg	Tablet, prolonged release	5,825,557 L.L
N07XX08	VYNDAMAX	B	Tafamidis - 61mg	61mg	Capsule	784,020,041 L.L
R05CB06	MUCOSOLVAN LA	B	Ambroxol HCl - 75mg	75mg	Capsule	345,368 L.L
A07EC02	ASACOL	B	Mesalazine - 400mg	400mg	Tablet, enteric coated	5,895,437 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 100mg	100mg	Injectable suspension, prolonged release	19,068,505 L.L
A07EC02	SALOFALK	B	Mesalazine - 500mg	500mg	Tablet, enteric coated	2,835,508 L.L
A10BK03	JARDIANCE	B	Empagliflozin - 25mg	25mg	Tablet, film coated	3,282,953 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 75mg	75mg	Injectable suspension, prolonged release	15,240,102 L.L
D07XA01	DAKTACORT	B	Hydrocortisone - 10mg/g, Miconazole nitrate - 20mg/g		Cream	208,296 L.L
M09AX01	HYALGAN	B	Hyaluronic acid (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	3,407,985 L.L
N03AF01	TEGRETOL	B	Carbamazepine - 2%	2%	Suspension	456,906 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 50mg	50mg	Injectable suspension, prolonged release	9,661,754 L.L
A07EC02	ASACOL	B	Mesalazine - 800mg	800mg	Tablet	6,833,439 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Tablet	739,202 L.L
L02BB03	CASODEX	B	Bicalutamide - 50mg	50mg	Tablet, film coated	3,777,541 L.L
M09AX10	EVRYSDI	B	Risdiplam - 0.75mg/ml	0.75mg/ml	Powder	865,644,067 L.L
N03AF04	ZEBINIX	B	Eslicarbazepine acetate - 800mg	800mg	Tablet	11,123,961 L.L
N05AX13	INVEGA SUSTENNA	B	Paliperidone palmitate - 150mg	150mg	Injectable suspension, prolonged release	27,480,995 L.L
R05D	123 COLD AND FLU	B	Phenylephrine HCl - 5mg, Carbinoxamine HCl - 3mg, Caffeine anhydrous - 30mg, Codeine phosphate - 8mg, Acetaminophen - 325mg		Tablet	409,552 L.L
S02D	CERULYSE	B	Xylene - 5g/100g	5g/100g	Drops solution	339,992 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Tablet, controlled release	4,945,340 L.L
A10BK03	JARDIANCE	B	Empagliflozin - 10mg	10mg	Tablet, film coated	3,282,953 L.L